Call Us Today @ 0172 - 4680800 | info@indswift.com | NSE - BSE
India imported APIs worth Rs 18,372.54 crore in 2016-17
 
India imported Active Pharmaceutical Ingredients (APIs) worth Rs 18,372.54 crore in 2016-17, of which the maximum was from China, Parliament was informed today.

APIs estimated to be worth Rs 12,254.97 crore were imported from China followed by the US at Rs 820.18 crore and Italy at Rs 701.85 crore in 2016-17, the Minister of State for Health Ashwini Kumar Choubey said in the Lok Sabha.

APIs worth Rs 485.11 crore were imported from Germany while APIs Rs 422.01 was imported from Singapore.

API is the term used to refer to the biologically active component of a drug product.

In 2015-16, the country imported APIs worth Rs 21,225.97 crore with ingredients worth Rs 13,853 being imported from China, followed by Germany at Rs 1054.71 crore and the US at Rs 980.38 crore.

(Health World)
 
Other Related News:
New long-acting, less-toxic HIV drug suppresses virus in humanized mice.
Diabetes linked with lower migraine risk.
United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?
Paracetamol may impair fertility of female offsprings: Study
Code for pharma marketing practices may be enforced soon.
India imported APIs worth Rs 18,372.54 crore in 2016-17
Study Shows Defending Against Environmental Stressors May Shorten lifespan (Research)
New Panel On Pricing
Maha FDA Seeks DCGI Intervention In Reducing Pack Size of Medicines
Zika Pandemic Remains Formidable Challenge To Medicine & Public Health, Say Experts